Christopher S. Meldrum, formerly Managing Director at Golden Pine Ventures. See sector focus and contact routes.
Christopher S. Meldrum, formerly Managing Director at Golden Pine Ventures, invests exclusively in **early-stage biotechnology and biomedical** companies, specifically avoiding pre-proof-of-concept technologies or one-product firms [1][4]. His firm typically provides **seed-stage** capital to spinouts from major universities, seeking to maintain a significant equity stake of **~50%** while focusing on the Research Triangle Park and Southeast US [1][3]. Notable portfolio companies he helped launch include **Kylin Therapeutics** (2009), **Arcato Laboratories** (2011 seed), and **Alterna Therapeutics** (2015), reflecting a thesis of nurturing innovative researcher-developed technologies into substantial businesses [1][5][6].
This profile is part of the StartupFundraising investor database: focus, portfolio history, disclosed location and contact routes, refreshed as new filings and rounds are ingested. Founders use it to check fit before reaching out and to find investors in Durham.
Investors like Christopher S. Meldrum · Full investor directory · Investor access · Company funding database